PDF herunterladen
Thromb Haemost 2010; 103(05): 984-988
DOI: 10.1160/TH09-07-0476
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Altered reference ranges for protein C and protein S during early pregnancy: Implications for the diagnosis of protein C and protein S deficiency during pregnancy

Joanne m. Said
1   Department of Perinatal Medicine, The Royal Women’s Hospital, Parkville, Victoria, Australia
2   The University of Melbourne, Department of Obstetrics and Gynaecology, Parkville, Victoria, Australia
,
Vera Ignjatovic
3   Department of Haematology, The Royal Children’s Hospital, Parkville, Victoria, Australia
4   Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia
,
Paul T. Monagle
3   Department of Haematology, The Royal Children’s Hospital, Parkville, Victoria, Australia
4   Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia
,
Susan P. Walker
2   The University of Melbourne, Department of Obstetrics and Gynaecology, Parkville, Victoria, Australia
5   Mercy Hospital for Women, Heidelberg, Victoria, Australia
,
John R. Higgins
1   Department of Perinatal Medicine, The Royal Women’s Hospital, Parkville, Victoria, Australia
2   The University of Melbourne, Department of Obstetrics and Gynaecology, Parkville, Victoria, Australia
6   Anu Research Centre, Department of Obstetrics & Gynaecology, University College Cork, Ireland
,
Shaun P. Brennecke
1   Department of Perinatal Medicine, The Royal Women’s Hospital, Parkville, Victoria, Australia
2   The University of Melbourne, Department of Obstetrics and Gynaecology, Parkville, Victoria, Australia
› Institutsangaben Financial support: We thank Bayer Diagnostics (Australia) and Diagnostica Stago (France) for supplying the reagents used in this study at discounted rates. This project has been supported by grants from the Kings Jubilee Fund (City of Melbourne), The Royal Women’s Hospital and The University of Melbourne (Australian Postgraduate Award and Felix Meyer Scholarship).
Weitere Informationen

Publikationsverlauf

Received: 25. Juli 2009

Accepted after major revision: 05. Januar 2010

Publikationsdatum:
22. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

Protein S, protein C and antithrombin are important regulators of coagulation. While deficiencies of these proteins have been linked to adverse pregnancy outcomes, testing for these deficiencies during pregnancy is limited by the use of non-pregnant reference ranges and a limited understanding of the changes that occur during pregnancy. Although several small studies have previously reported on the activity of these proteins during pregnancy, potentially important changes have been overlooked by continuing to compare the activity during pregnancy with non-pregnant reference ranges. In the current study, we investigated the activity of protein S, protein C and antithrombin during the first half of pregnancy in 440 otherwise asymptomatic women who went on to have uncomplicated singleton pregnancies. Consistent with previous studies, we found that antithrombin activity remained unchanged, while protein S activity decreased significantly to a mean level of 46%. We did not observe a progressive decrease in protein S during the second trimester as several studies have suggested previously. In contrast, we observed a potentially biologically significant increase in protein C activity throughout the first 22 weeks of pregnancy. Given the physiological role of protein C, we postulate that this increase may play a role in maintaining early pregnancy through both an anticoagulant and an inflammatory regulation pathway.

Keywords

Antithrombin - natural anticoagulants - protein C - protein S - pregnancy - reference ranges - thrombophilia - thrombosis
 

  • References

  • 1 O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003; 17: 385-396.
    CrossrefPubMedGoogle Scholar
  • 2 Cerneca F, Ricci G, Simeone R. et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Repr Biol 1997; 73: 31-36.
    PubMedGoogle Scholar
  • 3 Clark P, Brennand J, Conkie JA. et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 Uchikova E, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Repr Biol 2005; 119: 185-188.
    PubMedGoogle Scholar
  • 5 Dekker GA, de Vries JI, Doelitzsch PM. et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042-1048.
    CrossrefPubMedGoogle Scholar
  • 6 Kupferminc MJ, Eldor A, Steinman N. et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
    CrossrefPubMedGoogle Scholar
  • 7 Wickstrom K, Edelstam G, Lowbeer CH. et al. Reference intervals for plasma levels of fibronectin, von-Willebrand factor, free protein S, and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004; 64: 31-40.
    CrossrefPubMedGoogle Scholar
  • 8 Bremme K, Ostlund E, Almqvist I. et al. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132-137.
    PubMedGoogle Scholar
  • 9 Lefkowitz J, Clarke S, Barbour L. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996; 175: 657-660.
    CrossrefPubMedGoogle Scholar
  • 10 Oruc S, Saruc M, Koyuncu FM. et al. Changes in plasma activities of protein C and protein S during pregnancy. Aust N Z J Obstet Gynaecol 2000; 40: 448-450.
    CrossrefPubMedGoogle Scholar
  • 11 Tait RC, Walker ID, Islam SI. et al. Influence of demographic factors on anti-thrombin III activity in a healthy population. Br J Haematol 1993; 84: 476-480.
    CrossrefPubMedGoogle Scholar
  • 12 Dykes AC, Walker ID, McMahon AD. et al. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.
    CrossrefPubMedGoogle Scholar
  • 13 Faught W, Garner P, Jones G. et al. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995; 172: 147-150.
    CrossrefPubMedGoogle Scholar
  • 14 Monagle P, Barnes C, Ignjatovic V. et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Tait RC, Walker ID, Islam SI. et al. Protein C activity in healthy volunteers – influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1993; 70: 281-285.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Isermann B, Sood R, Pawlinski R. et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nature Med 2003; 09: 331-337.
    CrossrefPubMedGoogle Scholar
  • 17 Weiler H. Mouse models of thrombosis: thrombomodulin. Thromb Haemost 2004; 92: 467-477.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 18 Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29 (Suppl. 07) S48-S52.
    CrossrefPubMedGoogle Scholar
  • 19 Toltl LJ, Swystun LL, Pepler L. et al. Protective effects of activated protein C in sepsis. Thromb Haemost 2008; 100: 582-592.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 20 Murakami K, Okajima K, Uchiba M. et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol Lung Cell Mol Physiol 1997; 272: L197-202.
    CrossrefPubMedGoogle Scholar